Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination With Pazopanib for Refractory Soft Tissue Sarcoma

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01532687
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:29.122254+00:00
Published At
2021-02-09T00:00:00+00:00
Record Updated At
2021-09-27
Results Posted At
2021-02-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Adult Alveolar Soft Part Sarcoma", "Adult Angiosarcoma", "Adult Desmoplastic Small Round Cell Tumor", "Adult Epithelioid Hemangioendothelioma", "Adult Epithelioid Sarcoma", "Adult Extraskeletal Myxoid Chondrosarcoma", "Adult Extraskeletal Osteosarcoma", "Adult Fibrosarcoma", "Adult Leiomyosarcoma", "Adult Liposarcoma", "Adult Malignant Peripheral Nerve Sheath Tumor", "Adult Rhabdomyosarcoma", "Adult Synovial Sarcoma", "Adult Undifferentiated Pleomorphic Sarcoma", "Malignant Adult Hemangiopericytoma", "Recurrent Adult Soft Tissue Sarcoma", "Sarcoma", "Stage III Adult Soft Tissue Sarcoma AJCC v7", "Stage IV Adult Soft Tissue Sarcoma AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-09-27"
protocolSection.identificationModule.nctId
"NCT01532687"
protocolSection.identificationModule.officialTitle
"A Randomized, Double-Blind Phase II, Study of Gemcitabine Alone or in Combination With Pazopanib for Refractory Soft Tissue Sarcoma"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2021-02-09"

Study condition terms

  • Adult Alveolar Soft Part Sarcoma (protocolSection.conditionsModule.conditions)
  • Adult Angiosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Desmoplastic Small Round Cell Tumor (protocolSection.conditionsModule.conditions)
  • Adult Epithelioid Hemangioendothelioma (protocolSection.conditionsModule.conditions)
  • Adult Epithelioid Sarcoma (protocolSection.conditionsModule.conditions)
  • Adult Extraskeletal Myxoid Chondrosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Extraskeletal Osteosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Fibrosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Leiomyosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Liposarcoma (protocolSection.conditionsModule.conditions)
  • Adult Malignant Peripheral Nerve Sheath Tumor (protocolSection.conditionsModule.conditions)
  • Adult Rhabdomyosarcoma (protocolSection.conditionsModule.conditions)
  • Adult Synovial Sarcoma (protocolSection.conditionsModule.conditions)
  • Adult Undifferentiated Pleomorphic Sarcoma (protocolSection.conditionsModule.conditions)
  • Malignant Adult Hemangiopericytoma (protocolSection.conditionsModule.conditions)
  • Recurrent Adult Soft Tissue Sarcoma (protocolSection.conditionsModule.conditions)
  • Sarcoma (protocolSection.conditionsModule.conditions)
  • Stage III Adult Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Adult Soft Tissue Sarcoma AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.